The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
BioNumerik Reports Preclinical Antitumor Data On Two Novel Supercomputer Engineered Anticancer Agents At 89th Annual AACR Conference

- Novel class of highly lipophilic camptothecins, known as Karenitecins, demonstrates potent oral antitumor activity, acceptable safety and appear to be insensitive to common tumor-associated drug resistance mechanisms

- BioNumerik's novel chemoprotecting agent BNP7787 appears to completely protect against major toxicities associated with widely used platinum anticancer drugs such as cisplatinum

New Orleans, LA - March 30, 1998 -- BioNumerik Pharmaceuticals, Inc. this week presented new research results on two novel supercomputer-engineered small molecule agents designed to help address significant existing problems in current cancer therapy. These results continue to strengthen the correlation between actual experimental observations and the computational simulations provided by BioNumerik's innovative supercomputer simulations and mechanism based approach to new pharmaceutical discovery and development.

Regarding BioNumerik's BNP7787 and Karenitecins, Martin D. Abeloff, M.D., Director of the Johns Hopkins Oncology Center, stated, "These drugs have the potential to make a significant impact on current cancer therapy. The data reported by BioNumerik is particularly meaningful because the discovery and design of both of these agents was supported by BioNumerik's mechanism based computational studies and supercomputer simulations."

Frederick H. Hausheer, M.D., BioNumerik's Chairman and Chief Executive Officer, presented these findings at the 89th Annual Meeting of the American Association for Cancer Research held March 28 - April 1, 1998.

In a presentation titled "Karenitecins: A Novel Class of Orally Active Highly Lipophilic Topoisomerase I Inhibitors", the results presented by BioNumerik of studies conducted in BALB/c mice indicate that orally administered Karenitecin had excellent antitumor activity against solid tumors (prostate, colon, breast, lung) and had superior antitumor potency compared to existing camptothecin deriva
'"/>

Contact: Neil Cohen
neil@noonanrusso.com
212-696-4455 x. 205
Noonan/Russo Communications
30-Mar-1998


Page: 1 2 3 4 5

Related medicine news :

1. BioNumerik Reports Data On Two Novel Supercomputer Engineered Anticancer Agents At 90th Annual Meeting Of The AACR
2. BioNumerik Reports The Supercomputer Supported Discovery Of New, Non-Toxic Chemotherapy Protecting Agent
3. Abgenix Reports Positive Survival Data From A Phase II Trial Of ABX-CBL In Graft Versus Host Disease
4. Melanoma Patients Sentinel Lymph Nodes (SLNS) Play A Strong Role In Disease Prognosis, UCSF Study Reports
5. Irritable Bowel Syndrome The Focus Of Three UNC-CH Reports At Digestive Diseases Conference
6. UCSF-Harvard Team Reports Encouraging Results In Drug Study Of Mice With Cancer
7. Bone Marrow With Heart And Lung Transplants Reduces Rejection Of Transplanted Organs, Reports University Of Pittsburgh
8. Bone Marrow With Organ Transplants Reduces Rejection Of Transplanted Organs, Reports University Of Pittsburgh
9. Changes In Levels Of LDLc From Pre- To Post-Menopausal Years Not Valuable Indicator Of Heart Disease, Reports University Of Pittsburgh Researcher
10. Medicare Policy Contradicts Preferred Treatment For Precancerous Skin Conditions, Westwood Squibb Center For Dermatology Research Reports
11. International Study Finds Statins Raise Good Cholesterol, Wake Forest Physician Reports

Post Your Comments:
(Date:11/24/2009)... Slate and New Markets build on their combined str.... , Baltimore, Md. (PRWEB...latecap.com ), a private equity firm based in Balt...( www.newmarketsvp.com ), a venture capital firm b...at they have acquired Ecoast Sales Solutions, Ltd....
(Date:11/24/2009)... Sinusitis patients life is regularly impacted by ...cs non-invasive nasal sinus treatment with Nasal n...pes of Sinusitis without any limitation or interfe...rs found 82.9% of patients treated with Sinus Dyna...particle diameter of 3.2 µm had a “goo...
(Date:11/24/2009).../PRNewswire-USNewswire/--Newpeer-revieweddatafindi...nsinfectedwithchronichepatitisCvirushavereceivedan...atCongressneedstomoveurgentlyonbipartisanlegislati...veillanceefforts,the NationalViralHepatitisRoundta...congressionalaction,millionsofAmericansinfectedwit...
(Date:11/23/2009),, NEWYORK,Nov.23/PRNewswire/--Livingwithchronicpaincanbedifficult-andthestressoftheholidayseasoncanprovetobequitechallengingforthoselivingwithpain. ,, ListentothisreportfromPfizerInc.at: ,
(Date:11/23/2009)... After suffering from women,s hair loss for almost... and she,s sharing her progress and the secret beh...ugh the release of her video diaries which include... her treatment. , (PRWeb ...ferer Zsanett Siklosi has released the video diari...
Breaking Medicine News(10 mins):Health News:Slate Capital Group and New Markets Venture Partners Acquire eCoast Sales Solutions 2Health News:Slate Capital Group and New Markets Venture Partners Acquire eCoast Sales Solutions 3Health News:Sinusitis Treatment Using Nebulized Medications to Treat Sinusitis Rather than Sinus Surgery 2Health News:Sinusitis Treatment Using Nebulized Medications to Treat Sinusitis Rather than Sinus Surgery 3Health News:Sinusitis Treatment Using Nebulized Medications to Treat Sinusitis Rather than Sinus Surgery 4Health News:NVHR: New Data Finding Fewer than 1 in 5 Hepatitis C Patients Receiving Antiviral Therapy is 'Wake-Up Call' for Washington 2Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 2Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 3
(Date:11/23/2009)...e-FirstCall/-- CryoLife,Inc. (NYSE: CRY ),animplan...eprocessingcompany,announcedtodaythatitisscheduled...althCareConferenceatTheNewYorkPalaceHotelonDecembe...xecutiveofficerofCryoLife,Inc.,willprovideacorpora...dhostaquestionandanswersessionat4:30p.m.EasternTim...
(Date:11/23/2009)...RNewswire-FirstCall/--WoundManagementTechnologies,...rofspecialtymedicalproducts,announcedthatithasfile...ivemanagementbusinessupdatetoillustratethedevelopm...ncreased33.5%to$102,926vs.Q32008salesof$77,084. ,...27,892vs.Q32008shareholderequityof$(321,257) ,...
(Date:11/23/2009)...Newswire-FirstCall/--Pharmasset,Inc.(Nasdaq: VRUS ...partnerRoche(SWX:ROG.VX;RO.S,OTCQX:RHHBY),willcont...goingphase2btrialofRG7128,afirst-in-classnucleosid...hepatitisCvirus(HCV)infection.Thedecisionwasreache...gCommittee(DMC)ofallavailablesafetydatafromthefirs...
Breaking Medicine Technology:CryoLife to Present at 21st Annual Piper Jaffray Health Care Conference 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 2Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 3Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 4Life Science Leaders Discuss Strategies for Surviving the Financial Crisis at Yankee Public Relations Symposium 12692 1Life Science Leaders Discuss Strategies for Surviving the Financial Crisis at Yankee Public Relations Symposium 12692 2Life Science Leaders Discuss Strategies for Surviving the Financial Crisis at Yankee Public Relations Symposium 12692 3Life Science Leaders Discuss Strategies for Surviving the Financial Crisis at Yankee Public Relations Symposium 12692 4Life Science Leaders Discuss Strategies for Surviving the Financial Crisis at Yankee Public Relations Symposium 12692 5Cerebrospinal fluid shows Alzheimers disease deterioration much earlier 49359 1Cerebrospinal fluid shows Alzheimers disease deterioration much earlier 49359 2Stroke survivors report loss of sexual desire blurred gender roles anger and fatigue 49357 1Stroke survivors report loss of sexual desire blurred gender roles anger and fatigue 49357 2Stroke survivors report loss of sexual desire blurred gender roles anger and fatigue 49357 3Stroke survivors report loss of sexual desire blurred gender roles anger and fatigue 49357 4
Other News:
...ine directed at the three most globally important ...at the Dale and Betty Bumpers Vaccine Research Cen...gy and Infectious Diseases (NIAID), the vaccine in...nd C, which cause about 90 percent of all HIV infe...
...search Institute (TSRI) have designed a vaccine th... consequences of severe sepsis, an acute and often...0 Americans a year and millions more worldwide....... to clinical trials in humans, it has worked well ...
...older men is cost effective, according to a study ...andomised trial, researchers assessed the cost eff...ortic aneurysms in 67,800 men aged 65-74 years for...e 47 fewer deaths related to abdominal aortic aneu...
The third article about the role of the pharmaceutical industry in medicine--The Pharmaceutical Industry as a Medicines Provider--is published in this week's issue of THE LANCET.......David Henry from
health news:New HIV vaccine holds promise of global effectiveness 2health news:New HIV vaccine holds promise of global effectiveness 3health news:Sepsis vaccine proves protective in preliminary studies at The Scripps Research Institute 2health news:Sepsis vaccine proves protective in preliminary studies at The Scripps Research Institute 3health news:Pharmaceutical industry still failing health needs of less-developed countries 2
...ggers, director of Adolescent Medicine at Children...awarded the Peter E. Haas Public Service Award, on...ersity of California, Berkeley. The award recogni...ignificant voluntary public contribution to the be...
...ore accurate diagnostic test for Sjgrens (SHOW-gri...racterized by chronically dry eyes and dry mouth. ...ein biomarkers in the tears using highly sensitive...l studies as the first simple test for identifying...
...ry-grown organs and stimulated growth of muscle, b...g medical conditions was revealed at a recent Tiss... Baptist Medical Center. ......The symposium, spon... Society of Arthroscopy, Knee Surgery and Orthopae...
...ts will be uninsured at some point during the year...article in the April 11 issue of Archives of Inter......."Uninsured individuals are less likely to have...ces, to obtain timely care for acute medical probl...
health news:Painless test using teardrops may speed diagnosis of Sjgren's syndrome 2health news:Tissue engineering experts discuss orthopaedics applications 2health news:In years preceding medicare eligibility, many older adults at risk of being uninsured 2